ESUR Guidelines: Ovarian Cancer Staging and Follow-up

Overview

Journal Eur Radiol

Specialty Radiology

Date 2010 Sep 15

PMID 20839002

Citations 62

Authors

Rosemarie Forstner

Evis Sala

Karen Kinkel

John A Spencer

Affiliations

Soon will be listed here.

Abstract

Objective: To design clear guidelines for the staging and follow-up of patients with ovarian cancer, and to provide the radiologist with a framework for use in multidisciplinary conferences.

Methods: Guidelines for ovarian cancer staging and follow-up were defined by the female imaging subcommittee of the ESUR (European Society of Urogenital Radiology) based on the expert consensus of imaging protocols of 12 leading institutions and a critical review of the literature.

Results: Computed tomography (CT) with coverage of the base of the lungs to the inguinal region is regarded as the imaging technique of choice for preoperative staging. Critical diagnostic criteria are presented and the basis for a structured report for preoperative staging is outlined. Following primary treatment for ovarian cancer, clinical assessment and CA-125 are routinely used to monitor patients. For suspected recurrence, CT remains the imaging modality of choice, with positron emission tomography (PET)/CT emerging as the optimal imaging technique for suspected recurrence, particularly in patients with negative CT or magnetic resonance imaging (MRI).

Conclusions: CT is the imaging modality of choice for preoperative staging and detection of recurrence in patients with ovarian cancer.

Citing Articles

An Assessment of the Effectiveness of Preoperative İmaging Modalities (MRI, CT, and 18F-FDG PET/CT) in Determining the Extent of Disease Spread in Epithelial Ovarian-Tubal-Peritoneal Cancer (EOC).

Kandemir H, Sozen H, Kartal M, Ozkan Z, Topuz S, Salihoglu M Medicina (Kaunas). 2025; 61(2).

PMID: 40005316 PMC: 11857206. DOI: 10.3390/medicina61020199.

A clinicoradiological model based on clinical and CT features for preoperative prediction of histological classification in patients with epithelial ovarian cancers: a two-center study.

Li J, Wang W, Zhang B, Zhu X, Liu D, Li C Abdom Radiol (NY). 2025; .

PMID: 39982476 DOI: 10.1007/s00261-025-04842-x.

Ovarian cancer staging and follow-up: updated guidelines from the European Society of Urogenital Radiology female pelvic imaging working group.

Rizzo S, Avesani G, Panico C, Manganaro L, Gui B, Lakhman Y Eur Radiol. 2025; .

PMID: 39798005 DOI: 10.1007/s00330-024-11300-7.

Anatomy, Imaging, and Surgical Treatment of Thoracic Lymphadenopathies in Advanced Epithelial Ovarian Cancer.

Rizzo S, Gasparri M, Manganaro L, Del Grande F, Papadia A, Petrella F Cancers (Basel). 2024; 16(23).

PMID: 39682172 PMC: 11640282. DOI: 10.3390/cancers16233985.

Ovarian Cancer Staging-How CT Scan Descriptions Differ from Surgical Findings.

Cwiertnia A, Borzyszkowska D, Golara A, Tuczynska N, Kozlowski M, Poncyljusz W J Clin Med. 2024; 13(15).

PMID: 39124826 PMC: 11312800. DOI: 10.3390/jcm13154560.

References

Akin O, Sala E, Moskowitz C, Ishill N, Soslow R, Chi D . Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion. Radiology. 2008; 248(2):511-7. DOI: 10.1148/radiol.2482070371. View

Spencer J, Forstner R, Hricak H . Investigating women with suspected ovarian cancer. Gynecol Oncol. 2007; 108(2):262-4. DOI: 10.1016/j.ygyno.2007.10.007. View

Yoshida Y, Kurokawa T, Kawahara K, Tsuchida T, Okazawa H, Fujibayashi Y . Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer. AJR Am J Roentgenol. 2003; 182(1):227-33. DOI: 10.2214/ajr.182.1.1820227. View

Spencer J, Forstner R, Cunha T, Kinkel K . ESUR guidelines for MR imaging of the sonographically indeterminate adnexal mass: an algorithmic approach. Eur Radiol. 2010; 20(1):25-35. DOI: 10.1007/s00330-009-1584-2. View

Qayyum A, Coakley F, Westphalen A, Hricak H, Okuno W, Powell B . Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol. 2005; 96(2):301-6. DOI: 10.1016/j.ygyno.2004.06.054. View

Kim S, Kim S, Yang D, Kim K . Unusual causes of tubo-ovarian abscess: CT and MR imaging findings. Radiographics. 2004; 24(6):1575-89. DOI: 10.1148/rg.246045016. View

Kopka L, Rogalla P, Hamm B . [Multislice CT of the abdomen--current indications and future trends]. Rofo. 2002; 174(3):273-82. DOI: 10.1055/s-2002-20599. View

Gu P, Pan L, Wu S, Sun L, Huang G . CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2008; 71(1):164-74. DOI: 10.1016/j.ejrad.2008.02.019. View

Spencer J, Swift S, Wilkinson N, Boon A, Lane G, Perren T . Peritoneal carcinomatosis: image-guided peritoneal core biopsy for tumor type and patient care. Radiology. 2001; 221(1):173-7. DOI: 10.1148/radiol.2203010070. View

10.

Togashi K . Ovarian cancer: the clinical role of US, CT, and MRI. Eur Radiol. 2004; 13 Suppl 4:L87-104. DOI: 10.1007/s00330-003-1964-y. View

11.

Gadducci A, Cosio S . Surveillance of patients after initial treatment of ovarian cancer. Crit Rev Oncol Hematol. 2009; 71(1):43-52. DOI: 10.1016/j.critrevonc.2008.12.008. View

12.

Dachman A, Visweswaran A, Battula R, Jameel S, Waggoner S . Role of chest CT in the follow-up of ovarian adenocarcinoma. AJR Am J Roentgenol. 2001; 176(3):701-5. DOI: 10.2214/ajr.176.3.1760701. View

13.

Benedet J, Bender H, Jones 3rd H, Ngan H, Pecorelli S . FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000; 70(2):209-62. View

14.

Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

15.

Johnson W, Taylor M, Carrington B, Bonington S, Swindell R . The value of hyoscine butylbromide in pelvic MRI. Clin Radiol. 2007; 62(11):1087-93. DOI: 10.1016/j.crad.2007.05.007. View

16.

Funt S, Hricak H, Abu-Rustum N, Mazumdar M, Felderman H, Chi D . Role of CT in the management of recurrent ovarian cancer. AJR Am J Roentgenol. 2004; 182(2):393-8. DOI: 10.2214/ajr.182.2.1820393. View

17.

Coakley F, Choi P, Gougoutas C, Pothuri B, Venkatraman E, Chi D . Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology. 2002; 223(2):495-9. DOI: 10.1148/radiol.2232011081. View

18.

Kitajima K, Murakami K, Yamasaki E, Kaji Y, Fukasawa I, Inaba N . Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT. Eur J Nucl Med Mol Imaging. 2008; 35(10):1912-20. DOI: 10.1007/s00259-008-0890-2. View

19.

Fujii S, Matsusue E, Kanasaki Y, Kanamori Y, Nakanishi J, Sugihara S . Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol. 2007; 18(1):18-23. DOI: 10.1007/s00330-007-0732-9. View

20.

Kalra M, Maher M, Toth T, Schmidt B, Westerman B, Morgan H . Techniques and applications of automatic tube current modulation for CT. Radiology. 2004; 233(3):649-57. DOI: 10.1148/radiol.2333031150. View